obstetric or thrombotic-should receive therapy with heparin (usually LMWH) to improve pregnancy outcome and/or reduce risk of thrombosis. We strongly recommend combined low-dose aspirin and prophylactic-dose heparin (usually LMWH) for patients meeting criteria for OB APS This is based on evidence of moderate strength. In women with OB APS, we further strongly recommend treating with prophylactic-dose anticoagulation for 6-12 weeks post partum In pregnant women with thrombotic APS, we strongly